CD133 immunomagnetic separation: effectiveness of the method for CD133⁺ isolation from umbilical cord blood

References

• Rowe JM. Optimal management of adults with ALL. Br J Haematol. 2009;144:468–83.
   PubMed Web of Science ®Google Scholar
• Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, . Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. J Am Med Assoc (JAMA). 2009;30:2349–61.
   Google Scholar
• Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott–Aldrich syndrome. Blood. 2009;113:6288–95.
   PubMed Web of Science ®Google Scholar
• Filipovich A. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Bone Marrow Transplant. 2008;42(Suppl 1):S49–52.
   Google Scholar
• Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009;94:451–4.
   PubMed Web of Science ®Google Scholar
• Picardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apher Sci. 2010;42:289–97.
   PubMed Web of Science ®Google Scholar
• Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1–13.
   PubMed Web of Science ®Google Scholar
• Bauer N, Fonseca AV, Florek M, Freund D, Jaszai J, Bornhauser M, . New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs. 2008;188:127–38.
   PubMed Web of Science ®Google Scholar
• Meregalli M, Farini A, Belicchi M, Torrente Y. CD133(+) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther. 2010;10:1521–8.
   PubMed Web of Science ®Google Scholar
• Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(–)Lin(–) and CD34(+)Lin(–) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000;95:2813–20.
   PubMed Web of Science ®Google Scholar
• Dimitriou H, Vorgia P, Stiakaki E, Mavroudis D, Markaki EA, Koumantakis E, . In vitro proliferative and differentiating characteristics of CD133(+) and CD34(+) cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO). Potential implications for hematopoietic cell transplantation. Leuk Res. 2003;27:1143–51.
   PubMed Web of Science ®Google Scholar
• Robinson SN, Ng J, Niu T, Yang H, McMannis JD, Karandish S, . Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cell. Bone Marrow Transplant. 2006;37:359–66.
   PubMed Web of Science ®Google Scholar
• Singh K, Srivastava, A, Mathur N, Kumar S, Kumar L, Mukhopadhyay A, . Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method. Cytotherapy. 2009;11:768–77.
   PubMed Web of Science ®Google Scholar
• Senegaglia AC, Barboza LA, Dallagiovanna B, Aita CA, Hansen P, Rebelatto CL, . Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function? Exp Biol Med. 2010;235:119–29.
   Google Scholar
• Kekarainen T, Mannelin S, Laine J, Jaatinen T. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol. 2006;7:30–9.
   PubMedGoogle Scholar
• Jing Y, Moore LR, Schneider T, Williams PS, Chalmers JJ, Farag SS, . Negative selection of hematopoietic progenitor cells by continuous magnetophoresis. Exp Hematol. 2007; 35:662–72.
   PubMed Web of Science ®Google Scholar
• De Wynter EA, Coutinho LH, Pei X, Marsh JCW, Hows J, Luft T. Comparison of purity and enrichment of CD34 + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells. 1995;13:524–32.
   PubMed Web of Science ®Google Scholar
• 0391roviita P, Teramo K, Hiilesmaa V, Kekomaki R. Cord blood hematopoietic progenitor cell concentration and infant sex. Transfusion. 2005;45:613–21.
   Google Scholar
• Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, . AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–12.
   PubMed Web of Science ®Google Scholar
• Green CL, Loken M, Buck D, Deeg HJ. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML). Leukemia. 2000;14:770–2.
   PubMed Web of Science ®Google Scholar
• Miyoshi E, Noda K, Ko JH, Ekuni A, Kitada T, Uozumi N, . Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res. 1999;59:2237–43.
   Google Scholar